PTT-621

N/A

Report date: 2026/05/14 20:00:28
NMEFirst In Class

Base Information

Drug NamePTT-621
Drug Alias NamePTT-621PTT621
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-protein kinase 1 inhibitors
TargetsAlpha-protein kinase 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPyrotech (Beijing) Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPyrotech (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A